Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation
| Image |  |
|---|---|
| Description | scientific article published on 18 May 2006 |
| Author/s | |
| Publication date | May 18, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |